Clinical Research
The science is in.
It works.
Sublingual ketamine treatment is backed by peer-reviewed research, real-world clinical data, and tens of thousands of patient outcomes. Here's what the evidence shows.
Telehealth Delivery
Results that hold up
when care comes to you
Two landmark datasets, including the largest ever published, confirm that outcomes delivered via telehealth match in-clinic IV treatment.
The largest prospective telehealth trial of its kind
Nearly two-thirds of patients treated entirely online felt meaningfully better results on par with in-clinic IV ketamine. No clinic required.
62.8% meaningful response rate
Real-world dataset validating at-home outcomes
Over 11,000 patients tracked via telehealth, with machine-learning analysis confirming consistent, reliable results. Thousands of success stories — not just one.
11K+ patients tracked
Conditions
All studies referenced are peer-reviewed and published in indexed medical journals. Statistics reflect outcomes for sublingual or transmucosal ketamine specifically, not IV infusion. Individual results may vary. Sources: Lara et al. (2013) · Nguyen et al. (2015) · Hartberg et al. (2018) · Hull et al. (2022) · Hassan et al. (2022) · Mathai et al. (2024) · Beaglehole et al. (2025) · Francis (2025)
